润迈德医疗有限公司于2026年3月2日发布截至2026年2月28日的股份变动月报表。报告显示，公司注册股本及已发行股本在报告期内保持稳定，未发生新增发行、购回或注销股份等变动。
公司注册股本维持在3,800,000,000股，面值为每股0.0001港元，注册股本总额为380,000港元；已发行股份数为1,401,358,800股，与上月末一致。公司表示，截至2026年2月28日，公众持股量符合25%的上市规定要求。
本月股权激励方面，公司首个公开发售前购股权计划并无产生新股发行及库藏股转让，相关期权数量保持不变，仍为22,351,050股。公司强调，所有证券发行及库存股份管理均已遵守香港联交所《上市规则》和适用法律规定。
公告由联席公司秘书张亮签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.